Research and Development

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …

Roche has added to its portfolio of diagnostics products by acquiring US company BioImagene. The privately held Californian company specialises …

The American Society of Clinical Oncology conference, one of the most important dates in the pharmaceutical industry’s calendar, took place …

Novartis has joined the race to develop a ‘gene silencing’ treatment by signing a new deal with siRNA specialist Quark …

Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …

UK contract research organisation Synexus says it is reaping the benefits of its investments in Hungary in recent years, with …

Lilly is to abandon an Alzheimer’s drug in phase III development after results suggested it actually accelerated the disease rather …

Susan Aldridge reports on what some of the leading pharma companies are doing in the regenerative medicine and stem cells …

Merck has entered a $289 million agreement with Canadian company Alectos Therapeutics in a bid to find new Alzheimer’s drugs. …

Amgen’s potential head and neck cancer treatment Vectibix has failed to meet its primary endpoint of improving overall survival in …

Nottingham, UK-based cancer drug discovery and development company Pharminox has appointed Dr Marc Hummersone as research director. Marc first joined …

Investment in the beleaguered US biotechnology sector shot up in the second quarter of this year, but analysts say it’s …

Contract research organisation and pharma services company Quintiles is moving its European headquarters to Reading in the UK. Previously based …

Valuations are essential components of effective transactions in the life sciences industry

Sanofi-Aventis has signed a personalised medicine research alliance with US not-for-profit company Scripps Genomic Medicine. The company is part of …